Home › Compare › GNTTF vs EQR

GNTTF vs EQR: Dividend Comparison 2026

GNTTF yields 20000.00% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GNTTF wins by $52481917574412746752.00M in total portfolio value
10 years
GNTTF
GNTTF
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full GNTTF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — GNTTF vs EQR

📍 GNTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGNTTFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GNTTF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GNTTF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNTTF
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, GNTTF beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNTTF + EQR for your $10,000?

GNTTF: 50%EQR: 50%
100% EQR50/50100% GNTTF
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

GNTTF
No analyst data
Altman Z
-0.3
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNTTF buys
0
EQR buys
0
No recent congressional trades found for GNTTF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGNTTFEQR
Forward yield20000.00% ✓4.73%
Annual dividend / share$2.00$2.77 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$52481917574412746752.00M ✓$40.5K
Annual income after 10y$51,970,745,957,167,775,000,000,000.00 ✓$3,819.61
Total dividends collected$52448189483771600896.00M ✓$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: GNTTF vs EQR ($10,000, DRIP)

YearGNTTF PortfolioGNTTF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$2,010,700$2,000,000.00$11,248$547.57+$2.00M → GNTTF
2$377,983,225$375,831,775.70$12,701$666.53+$377.97M → GNTTF
3$66,433,479,469$66,029,037,418.28$14,405$814.59+$66433.47M → GNTTF
4$10,916,985,471,987$10,845,901,648,955.73$16,413$999.84+$10916985.46M → GNTTF
5$1,677,384,363,769,318$1,665,703,189,314,291.80$18,795$1,232.92+$1677384363.75M → GNTTF
6$240,985,175,079,139,100$239,190,373,809,905,920.00$21,639$1,527.95+$240985175079.12M → GNTTF
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$25,057$1,903.80+$32373573631143.67M → GNTTF
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$29,197$2,385.87+$4066766648320630.00M → GNTTF
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$34,250$3,008.70+$477730483406513344.00M → GNTTF
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$40,467$3,819.61+$52481917574412746752.00M → GNTTF

GNTTF vs EQR: Complete Analysis 2026

GNTTF — Stock

GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin. Their platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs.

Full GNTTF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this GNTTF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNTTF vs SCHDGNTTF vs JEPIGNTTF vs OGNTTF vs KOGNTTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.